| Bioactivity | Dasatinib analog-1 (compound 5826) inhibits CYP3A4 viability with a Ki value of 5.4 μM. Dasatinib analog-1 blocks the formation of glutathione adducts[1]. | ||||||||||||
| Name | Dasatinib analog-1 | ||||||||||||
| CAS | 1174416-41-1 | ||||||||||||
| Formula | C22H25ClFN7O2S | ||||||||||||
| Molar Mass | 506.00 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Xiaohai Li, et al. Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways. Drug Metab Dispos. 2009, 37, 6. |
Dasatinib analog-1
CAS: 1174416-41-1 F: C22H25ClFN7O2S W: 506.00
Dasatinib analog-1 (compound 5826) inhibits CYP3A4 viability with a Ki value of 5.4 μM. Dasatinib analog-1 blocks the f
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.